{"schema_version":"secwatch.filing_event.v1","accession":"0001554795-23-000184","form_type":"8-K","ticker":null,"cik":"0001500123","company_name":"Item 9 Labs Corp.","filed_at":"2023-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.083302+00:00","generated_at":"2026-06-14T18:11:49.419368+00:00","sec_items":["5.02","8.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Item 9 Labs CEO resigns, Chairman takes interim role, layoffs announced","bullets":["CEO Michael Weinberger resigned May 17, will stay as Strategic Advisor; no disagreement cited.","Chairman Douglas Bowden appointed Interim CEO effective May 22, 2023.","Director Jeffrey Rassas (former CSO) named Strategic Advisor for capital markets and IR.","Company cutting operating expenses including employee layoffs to stabilize cash flows."],"urls":{"canonical":"https://secwatch.observer/filing/0001554795-23-000184","json":"https://secwatch.observer/filing/0001554795-23-000184.json","markdown":"https://secwatch.observer/filing/0001554795-23-000184.md","text":"https://secwatch.observer/filing/0001554795-23-000184.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500123/000155479523000184/0001554795-23-000184-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500123/000155479523000184/inlb0522form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T18:11:49.419368+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a113781cbb","claim":"Douglas Bowden was appointed as Interim Chief Executive Officer at Item 9 Labs Corp..","evidence_excerpt":"On May 22, 2023, the Board appointed Mr. Douglas Bowden, age 63, as the Company’s Interim Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1500123/000155479523000184/0001554795-23-000184-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"e13bb0f888","claim":"Michael Weinberger resigned as Chief Executive Officer at Item 9 Labs Corp..","evidence_excerpt":"On May 17, 2023, Mr. Michael Weinberger voluntarily resigned as Chief Executive Officer and member of the Board of Directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1500123/000155479523000184/0001554795-23-000184-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}